Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-03-25 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 120 shares of Common Stock at $536.97 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 49,893.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40 shares of Common Stock at $538.7333 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 49,853.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 440 shares of Common Stock at $540.5145 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 49,413.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,699 shares of Common Stock at $541.7496 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 47,714.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,833 shares of Common Stock at $542.6579 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 45,881.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,721 shares of Common Stock at $543.6791 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 44,160.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,544 shares of Common Stock at $544.6514 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 42,616.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 911 shares of Common Stock at $545.7165 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 41,705.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 373 shares of Common Stock at $546.5881 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 41,332.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 459 shares of Common Stock at $547.7801 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 40,873.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 360 shares of Common Stock at $548.5237 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,518.00 | Footnotes: F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F15
• Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 69,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $547.29 to $548.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $548.30 to $548.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F13: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F14: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F15: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F2: This transaction was executed in multiple trades at prices ranging from $538.63 to $539.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $540.05 to $540.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $541.175 to $542.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $542.18 to $543.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $543.18 to $544.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $544.19 to $545.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $545.20 to $546.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $546.275 to $547.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.